AG真人官方

Stephanie Coon, SVP Strategy at Vital Farms, Inc. (VITL), reported an insider sale. On 08/12/2025 she disposed of 10,005 shares of Vital Farms common stock in transactions executed at a weighted average price of $46.15 per share. After the sale she beneficially owned 45,779 shares. The filing notes 359 shares included in the post-transaction total were purchased on May 15, 2025 under the company Employee Stock Purchase Plan in an exempt transaction. The Form 4 was signed by an attorney-in-fact on 08/14/2025.

Form 144 notice for Vital Farms, Inc. (VITL): The filer proposes to sell 3,393 shares of Common stock with an aggregate market value of $161,981.82. The shares are scheduled for sale on or about 08/14/2025 on NASDAQ. The securities were acquired as Restricted Stock Units from the issuer on 03/17/2024 and the acquisition/vesting date is recorded as 03/17/2024. The filing also discloses three prior 10b5-1 sales by the same account: 1,200 shares sold on 06/12/2025 for $38,316.00, 1,200 shares sold on 07/11/2025 for $46,764.00, and 1,200 shares sold on 08/11/2025 for $54,672.00. Certain filer identification fields (CIK/Name) and contact details are not provided in the visible content.

Vital Farms, Inc. is the subject of a Form 144 reporting a proposed sale of 6,086 common shares with an aggregate market value of $290,376.64, slated for sale on 08/14/2025 on Nasdaq. The filing shows these securities were acquired on 08/11/2025 as a stock bonus from Vital Farms Inc, where the holder received 18,475 shares and now proposes to sell a portion. The company has 44,685,980 shares outstanding, so the proposed sale represents approximately 0.014% of outstanding shares. The notice states there were no securities sold in the past three months by the reporting person and includes the standard representation that the seller is not aware of any undisclosed material adverse information.

Vital Farms, Inc. filed a Form 144 reporting a proposed sale of 20,000 common shares through J.P. Morgan Securities LLC on Nasdaq with an approximate sale date of 08/13/2025. The filing lists an aggregate market value of $924,200 and shows 44,685,980 shares outstanding.

The securities were acquired on 01/06/2015 in a private transaction from the issuer, with an original acquisition amount of 129,230 shares and payment dated 01/06/2015. The filing reports "Nothing to Report" for securities sold in the past three months. The document includes the standard certification that the filer does not know of any undisclosed material adverse information; certain fields such as the filer relationship to the issuer and the notice date are not specified in the provided text.

Peter Nicholas Pappas, identified as a director and an officer (CSO and President, Eggs) of Vital Farms, Inc. (VITL), reported a sale of common stock on 08/11/2025. The Form 4 shows 2,811 shares sold at $45.35 and reports 65,430 shares beneficially owned by the reporting person after the transaction. The filing also discloses acquisition of 500 shares on May 15, 2025 under the company employee stock purchase plan and corrects a prior one-share understatement in a December 2, 2024 filing. The Form is signed by an attorney-in-fact on behalf of the reporting person.

Wrede Thilo, identified as Chief Financial Officer of Vital Farms, Inc. (VITL), reported a sale of common stock on 08/11/2025. The filing shows 1,200 shares were disposed of at a reported price of $45.56 per share.

After the transaction the reporting person beneficially owned 54,987 shares. The filing states the sale was made pursuant to a Rule 10b5-1 trading plan adopted March 13, 2025. The Form 4 was submitted by one reporting person and lists a C/O Vital Farms Austin address.

Vital Farms, Inc. (Form 144) proposes the sale of 10,005 shares of common stock through Morgan Stanley Smith Barney LLC on NASDAQ, with an aggregate market value of $461,714.74 against total outstanding shares of 44,685,980. The proposed approximate sale date is 08/12/2025.

The 10,005 shares were acquired by the seller through restricted stock vesting under a registered plan on three dates: 03/10/2024 (5,662), 03/13/2024 (2,882), and 08/09/2024 (1,461). The filing reports "Nothing to Report" for securities sold in the past three months. Several administrative fields in the form (filer CIK/CCC, contact details, issuer address, date of notice, signature) are not provided in the supplied content.

Vital Farms, Inc. submitted a Form 144 reporting a proposed sale of 50,100 common shares with an aggregate market value of $2,312,115.00. The form lists 44,685,980 shares outstanding and an approximate sale date of 08/12/2025 on NASDAQ. The broker named is Morgan Stanley Smith Barney LLC. Acquisition details show 19,552 restricted stock units acquired on 03/10/2023 and 30,548 shares from previously exercised options acquired on 10/12/2023 (the exercised options were paid in cash). No securities were reported sold in the past three months. The filing does not disclose the filer鈥檚 CIK or the filer鈥檚 relationship to the issuer, which limits the ability to confirm whether this is an affiliate/insider sale.

Vital Farms, Inc. (VITL) filed a Form 144 reporting a proposed sale of 2,811 shares of common stock through Morgan Stanley Smith Barney LLC on the NASDAQ, with an aggregate market value of $127,478.85. The filing lists 44,257,535 shares outstanding, and gives an approximate sale date of 08/11/2025. The notice states the seller acquired the shares through restricted stock vesting under a registered plan on 11/27/2024 (501 shares) and 03/13/2025 (2,310 shares).

The filer reports no securities sold in the past three months and includes the standard representation that the seller does not know any material adverse information about the issuer that has not been publicly disclosed.